A September 24, 2022, New York Times article found that the hospital wasn’t reinvesting profits from drug sales into its facility that served low-income patients and improving their care.
Instead, it was investing the money in Bon Secours’ facilities in the city’s wealthier neighborhoods.
This is unfortunately not the only city where hospitals in wealthier communities are taking money from low-income areas.
CAGW has been sounding the alarm about abuse of the 340B Drug Discount program and the need for reforms for more than a decade.
We have pointed out the lack of transparency over the use of the 340B and how the failure to define a patient has caused program growth and exploitation to explode across the country.
Now, we’d like you to join us.
John, do you support reforms like:
✔ Clearly defining who qualifies as a 340B patient?
✔ Requiring verification of patient eligibility for every prescription?
✔ Increasing transparency into the use of 340B funds?
✔ Requiring qualified patients to be treated at a 340B facility and receive a prescription related to the diagnosis for their care?
✔ Closing loopholes that allow hospitals in wealthy communities to siphon profits from hospitals in low-income communities?
Please take two minutes to complete our urgent survey about which 340B reforms are most important to you.
Your input will help us show Congress exactly what American taxpayers want to see changed.
.png "CAGW Logo")
